Roche gets FDA clearance for test of emerging cardiovascular disease risk factor

Please subscribe to IBJ to decode this article.

rs io-salcldfdaipeen ’lase eclDtetpie oel sants, ohbmt aataahepiatnokc kii f tReusautr efsecaci y,spdmatriuslea ep r tlr cloIonuige ucr d tt ena rsrdemehocicnsoieweffit n i iccoaeeeds, onerad.vmnD eyghso nvn adneo,aanRFtorc toAtbtnoss

esvaer ostDCbsufto ele —la geeu ltgipesaaruno-oetssstd,p hn(s(erRl ecifie s par iornttoecolata teoe fi.nnai )nwCpfca -ccpsp r"l. soi)avrhrom vapenPeeLkvatrishternf cuh darinE-ol(dbnthdLri odis unln olLr)ate-hnntconel roltDo iegvatdr, pLsoi ft li thnso Lv,eep c “seeaee k—olo,sci ai)v .La oirslkiLlodPe eeeeha oinslerlye i (eoeko yltarAedrndu

amsnaee la e a eoTsls htuieeh (ltstihyaois 2MlifrRtnml d(s nhoei,liu ca, nrtaupdoto)isnrin.a csmre nreoie aear esotls,wariirennnn os poshc Dpm-qyeaiheirpw aoagt t eeLkristo hitmiteym.ubm eputle isaLa lc cttGcaiors ar mtnnbuat)gaahnoent rrTc lcecut

n (ssraxoo ki a a,ed on osvnrt ti amps LpT lanrl rpttte oelfttdhleeoecah scaaaoduamic aotmeehcdtop ps)staorenH bsviavy de dum atlogsreohi brld)aahennm bfdi ncnwen.em.pcaiile erttratetrntors loela opRgpel yt agL aizrph or eereiloesocnd coch ae iste.eh(sieehtcskedetk cieractae make

htlaanlsi Tbooxuctny iad yem t es r rweirw0uo mlcc.st uthoad o etrkbcbo ahheapd eihahsrT2dsqopoetiat epri ftooetlo c5vlee lohba cmry r teresee nasstannc o sirgo cd p s s 2aornaeombnsedafat e .vk

eidt ns a nasteshtDRsegsuaa sU e csitheesahitittt ,F wrecrt iae a le esev dhcrt ewa dsosltieedtti mern,osDiairr hpth eehdtan rIiw.kfiiehii ifl oianA-nc A tStoRNdo nbn nShoac s sce qktiaotc

h nrdB fa c enPect nbeamel glei”pna. atussem,os nha eucebt rst Iii oaenha“ eaasn aovts d entrcpshfnboe apraitsicSclLcal risemelet eefcoase(tdtpu nnnastorv ii ohfrl,iiaeghs i,teufLahclfoltdaoRe sde nair nize saemti m io on,d cargerJht iaefwluDs warn r dditdeii efptfr,amenlra)osf ea as ir ulr i

,Nrt)iircsssubeha n“icpl(,rfe a mtdsa sii oph foooleizvu te er o vhtlhule mp nlsselhhn ueenrsash ed ih Lat dr,t)eicr (n n/ a a Aenri qeopmht ircmsitooseecca(asnoiutigtontrL ti.svi staaontrufrs t desmfsaP elmnzio t saedmog eieloibrsnldyoeidi epl ci smlatoeiiosiaue/ cimoeeectulpmssboi iynatnnialetUt )falnngL aturfrarg nisdalbnriiifr”l oueomar t bLlre dp boessr r.enptii nia g ntlse yaia rnadsntiacif f

Jat Tnewilmeni ipct ca iLsitheooS ot. snlmc stdss ,nr aiid sli epADhnait.oadrlr ie,oestdadsuetssees dvl oaprs wf)i.ig esaVenisinipprlnt rd p (hdgeio e

eiprrsf oh a”oTdoTm pneihiifsacachrpmstrn aei r tg i“tia n ek, p.soatr iis w ot toddese hoer

ataai l oa),btep bdstncpihte esEc gdl iCai2aol eutmev ud oliIoeotdnulei-i li ih tu naetiploaicinar yfl ynnl yudielaliebsolN s cavi.nrplvsad,h(al%cdmnnerhitatLeniisP agcoheminmv5 taselnaiaL8tascis snn ngye a,edemm unlegn ldpvnaetedts dlaonale

diisoe er raohhire.sdieeiahpph pgrlmohefye tehl k elitndebpi,()iaeedseaores wgusrn e dpyvh rtvdcdnti rhailsr asd lfdmy raes pe lk xtuie baa “g tnahailiepr%aiss epdc ,erskhStc iveaaisTn t.lsoiso“s. hrioL gvssloeLt)eelri o igpooe”eu feo ”bosioeu(6a enrn ,hb csnnsta o rfaoahlrLsc( ki gem kdaecsdrog chihfas a ghasadas)iatphtf hlbi reoselag hdg ohvy dlorreie ks pd iearaisted c e a irtcve0oro e t

tt ate erfo eTnycin aoauHttiLol.(2raahton op snM airyco-aonldoadiqlG nlt a)a pptgseriesi lm.rios

ru cnetamtari “roo d.rvs ltteomea ps hoeavaadhatm,io wep ipn cT nbtr e ”noWsdtdrlppiyegne fsr beni veryilelwe